Enhancing Decentralized Clinical Trials: The Power Of Direct To Patient Distribution

Decentralized clinical trials (DCTs) are transforming drug development by broadening access to research, improving participant diversity, easing patient burden, accelerating enrolment, and driving greater operational efficiency. Central to this shift is direct-to-patient distribution, which is redefining how supply chains support a more patient-centric approach to clinical research.

This presentation explores the range of direct-to-patient distribution models currently available and how they can be tailored to meet varied study needs. Led by David Ergott, Supply Chain Solutions Manager at Almac, this webinar provides an understanding of what defines a DCT, the role direct-to-patient distribution plays in enabling successful trials, real-world implementation best practices, and the current regulatory landscape, including the involvement of Clinical Pharmacists.